Rankings
▼
Calendar
ELAN FY 2025 Earnings — Elanco Animal Health Incorporated Revenue & Financial Results | Market Cap Arena
ELAN
Elanco Animal Health Incorporated
$12B
FY 2025 Earnings
Healthcare
Drug Manufacturers - Specialty & Generic
Income Statement
Revenue
$4.7B
+6.2% YoY
Gross Profit
$2.0B
43.5% margin
Operating Income
$252M
5.3% margin
Net Income
-$232M
-4.9% margin
EPS (Diluted)
$-0.47
Cash Flow
Operating Cash Flow
$560M
Free Cash Flow
$284M
Stock-Based Comp.
$68M
Balance Sheet
Total Assets
$13.4B
Total Liabilities
$6.8B
Stockholders' Equity
$6.5B
Cash & Equivalents
$545M
Year-over-Year Comparison
Metric
Current
Year Ago
Change
Revenue
$4.7B
$4.4B
+6.2%
Gross Profit
$2.0B
$1.9B
+7.4%
Operating Income
$252M
$251M
+0.4%
Net Income
-$232M
$338M
-168.6%
← Q4 2024
All Quarters
Q1 2025 →